Redx Oncology Ltd is a subsidiary of Redx Pharma, a UK-based technology development resource for the global pharmaceutical market.
The application of Redox Switch™ in oncology gives the company the opportunity to deliver multiple development candidates across a range of mechanistic approaches in cancer treatment.
Redx Oncology is taking advantage of the local knowledge base and new biopharmaceutical laboratory infrastructure being created in central Liverpool. The company is working closely with its partners in the University of Liverpool, the Royal Liverpool University Hospital, the Liverpool Cancer Research UK Centre and Liverpool City Council (Liverpool Vision) to achieve its goal of creating new clinical candidates in support of the fight against cancer.
Monitor the research progress of Redx Oncology: Pipeline